HR 4139 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend title XVIII of the Social Security Act to provide for adjustments to the Medicare part D cost-sharing reductions for low- income individuals.
Summary
The bill amends Medicare Part D to reduce cost-sharing (copayments) for low-income individuals receiving prescription drug coverage. Starting in 2026, generic drugs will have a $0 copayment for eligible low-income beneficiaries, while other drugs will have copayments based on 2023 amounts. In subsequent years, copayments for non-generic drugs will increase only by the annual consumer price index inflation rate, rather than at higher rates.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
1 cosponsor
Money behind the sponsor
Top reported contributors to Morgan Mcgarvey’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $37,200
- THE KIDZ CLUB $22,200
- NORTON HEALTHCARE $15,850
- DANNY WIMMER PRESENTS $14,950
- GOLDBERG SIMPSON $13,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Morgan Mcgarvey → · Outside spending →
Actions (2)
- Jun 25, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Jun 25, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
June 25, 2025
Mr. McGarvey (for himself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to provide for adjustments to the Medicare part D cost-sharing reductions for low- income individuals.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Cutting Copays Act”.
SEC. 2. ADJUSTMENTS TO MEDICARE PART D COST-SHARING REDUCTIONS FOR LOW- INCOME INDIVIDUALS.
Section 1860D-14(a) of the Social Security Act (42 U.S.C. 1395w- 114(a)) is amended in paragraph (1)(D)(ii)—
(1) by striking “that does not exceed $1 for” and all that follows through the period at the end and inserting “that does not exceed—
“(I) for plan years before plan year 2026— “(aa) for a generic drug or a preferred drug that is a multiple source drug (as defined in section 1927(k)(7)(A)(i)), $1 or, if less, the copayment amount applicable to an individual under clause (iii); and “(bb) for any other drug, $3 or, if less, the copayment amount applicable to an individual under clause (iii); and”; and
(2) by adding at the end the following new subclauses:
“(II) for plan year 2026— “(aa) for a generic drug, $0; and “(bb) for any other drug, the dollar amount applied under this clause (after application of paragraph (4)(A)) for plan year 2023 for a drug described in subclause (I)(bb); and
“(III) for a subsequent year, the dollar amount applied under this clause for the previous year for the drug, increased by the annual percentage increase in the consumer price index (all items; U.S. city average) as of September of such previous year.”. <all>
Comments